RE Kohler, RB Wagner, K Careaga… - Human Vaccines & …, 2023 - Taylor & Francis
ABSTRACT HPV vaccination has potential to prevent 90% of HPV-associated cancers. The Advisory Committee on Immunization Practices recommends HPV vaccination for 11-and 12 …
K Saxena, O Patterson-Lomba… - Frontiers in …, 2024 - frontiersin.org
Introduction Routine human papillomavirus (HPV) vaccination in the US is recommended at ages 11 or 12 years and can be given at age 9. Vaccination completion rates among …
J Isher-Witt, S Foley, A Hassan, A Sloan… - Human Vaccines & …, 2023 - Taylor & Francis
ABSTRACT The American Cancer Society collaborated with a range of healthcare partners in 2020–2022 to implement quality improvement clinical interventions with the goal of …
LN Mansfield, BZ Kahn, S Kokitkar, KI Kritikos… - Vaccine, 2024 - Elsevier
Background Standing orders may improve HPV vaccination rates, but clinical staff's readiness to use them has not been well-explored. We sought to explore benefits and …
RB Perkins, S Humiston, K Oliver - Human Vaccines & …, 2023 - Taylor & Francis
HPV vaccination has been shown in both clinical trials and longitudinal population studies to reduce infection, precancer, and cancer. 1–3 Its safety has been demonstrated through …
A Ibrahim-Ojoawo, N Powe, R Rogers… - Cancer …, 2024 - journals.sagepub.com
Objective The introduction of the Human Papillomavirus (HPV) vaccine has led to future decline in prevalence of HPV-causing cancers; however, disparities in early HPV vaccine …
CJ Miller, A Boopathi, SR Slovin, Z Gao, K Maiden… - Academic …, 2024 - Elsevier
Objective HPV infection is associated with a large burden of disease prevalence, morbidity, and known disparities. HPV vaccination rates remain lower than other childhood …
Immunization platform visits are not new. Since babies have been vaccinated with the diphtheria, tetanus toxoid, and pertussis (ie, DTP), and smallpox vaccines in the late 1940s …
A Bandala Jacques - 2023 - jscholarship.library.jhu.edu
Background: Early initiation (ages 9-10) of the HPV vaccine series increases the likelihood of series completion. Individual-and county-level factors, such as race, ethnicity, income, and …